Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Gene Therapy to Target CD19 and CD22 for Oncology by Chongqing Precision Biotech for B-Cell Leukemia: Likelihood of Approval
Gene Therapy to Target CD19 and CD22 for Oncology is under clinical development by Chongqing Precision Biotech and currently in...
Data Insights
Gene Therapy to Target CD19 and CD22 for Oncology by Chongqing Precision Biotech for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
Gene Therapy to Target CD19 and CD22 for Oncology is under clinical development by Chongqing Precision Biotech and currently in...